Abstract
Purpose
Unrecognized and untreated hyperthyroidism leads to serious clinical complications with adverse outcomes for patients and increasing costs for the health care system. Hence, adequate knowledge of the epidemiological features of such condition is desirable to plan effective interventions. The aim of our study was to estimate incidence and prevalence of hyperthyroidism in the mildly iodine-deficient Italian Region of Piedmont.
Methods
A retrospective cohort study was conducted using Administrative Health Databases of the Piedmont Region, Italy (2012–2018). Hyperthyroidism cases were defined as the subjects who had at least one of the following claims: (i) hospital discharge records with hyperthyroidism diagnosis code; (ii) exemption from co-payment for hyperthyroidism; (iii) prescription of one of the following medications: methimazole, propylthiouracil, or potassium perchlorate.
Results
The overall prevalence was 756 per 100,000 inhabitants [95% CI 748–764], and the overall incidence was 81 per 100,000-person year [95% CI 80–82]. The prevalence and incidence increased with age and were two-fold higher among women than men. Women also showed two distinct peaks in incidence at the age of 30 and 50; after the age of 60, the trend became similar between sexes. With regard to the geographic distribution, an increasing gradient of incidence was observed from the northern to the south-western areas of the Region.
Conclusion
This is the first Italian study based on health databases to estimate the incidence and prevalence of hyperthyroidism in the general population. This approach can represent an inexpensive and simple method to monitor patterns of hyperthyroidism in iodine-deficient areas.
Similar content being viewed by others
References
M.P.J. Vanderpump, W.M.G. Tunbridge, J.M. French, D. Appleton, D. Bates, F. Clark, J. Grimley Evans, D.M. Hasan, H. Rodgers, F. Tunbridge, E.T. Young, The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. 43, 55–68 (1995)
D.S. Ross, H.B. Burch, D.S. Cooper, M.C. Greenlee, P. Laurberg, A.L. Maia, S.A. Rivkees, M. Samuels, J.A. Sosa, M.N. Stan, 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26, 1343–1421 (2016)
J.V. Hennessey, J.R. Garber, K.A. Woeber, R. Cobin, I. Klein, American association of clinical endocrinologists and American college of endocrinology position statement on thyroid dysfunction case finding. Endocr. Pract. 22, 262–270 (2016)
K.K. Miller, G.H. Daniels, Association between lithium use and thyrotoxicosis caused by silent thyroiditis. Clin. Endocrinol. 55, 501–508 (2001)
S. Danzi, I. Klein, Thyroid hormone and the cardiovascular system. Med. Clin. N. Am. 96, 257–268 (2012)
B. Biondi, G.J. Kahaly, Cardiovascular involvment in patients with different causes of hyperthyroidism. Nat. Rev. Endocrinol. 6, 431–443 (2010)
J.V. Parle, P. Maisonneuve, M.C. Sheppard, P. Boyle, J.A. Franklyn, Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358, 861–865 (2001)
Y. Ono, S. Ono, H. Yasunaga, H. Matsui, K. Fushimi, Y. Tanaka, Factors associated with mortality of thyroid storm: analysis using a national inpatient database in Japan. Medicine 95, e2848 (2016)
A.P. Delitala, M.G. Pilia, L. Ferreli, F. Loi, L. Balaci, D. Schlessinger, F. Cucca, E. Medicine, Prevalence of unknown thyroid disorders in a Sardinian cohort. Eur. J. Endocrinol. 171, 143–149 (2015)
P.N. Taylor, D. Albrecht, A. Scholz, G. Gutierrez-buey, J.H. Lazarus, C.M. Dayan, O.E. Okosieme, Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14, 301–316 (2018)
J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T 4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002)
A.G. Madariaga, S.S. Palacios, F. Guillén-grima, J.C. Galofré, The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J. Clin. Endocrinol. Metab. 99, 923–931 (2014)
A. Asban, S.K. Chung, M.A. Tresler, P. Huilgol, R. Xie, J.K. Kirklin, C.J. Balentine, B.M. Lindeman, H. Chen, Hyperthyroidism is underdiagnosed and undertreated in 3336 patients: an opportunity for improvement and intervention. Ann. Surg. 268, 506–512 (2018)
M. Caputo, A. Ucciero, C. Mele, L. De Marchi, C. Magnani, T. Cena, P. Marzullo, F. Barone-Adesi, G. Aimaretti, Use of administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region, Italy. J. Endocrinol. Investig. 42, 397–402 (2018)
C.B. Giorda, P. Carnà, F. Romeo, G. Costa, B. Tartaglino, R. Gnavi, Prevalence, incidence and associated comorbidities of treated hypothyroidism: an update from a European population. Eur. Soc. Endocrinol. 176, 533–542 (2017)
F. Brandt, M. Thvilum, D. Almind, K. Christensen, A. Green, T.H. Brix, Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study. PLoS ONE 8, 1–6 (2013)
A. Olivieri, P. Vitti (eds). Attività di monitoraggio del programma nazionale per la prevenzione dei disordini da carenza iodica. Roma: Istituto Superiore di Sanità (2014). (Rapporti ISTISAN 14/6)
P. Laurberg, C. Cerqueira, L. Ovesen, L.B. Rasmussen, H. Perrild, S. Andersen, I.B. Pedersen, A. Carlé, Iodine intake as a determinant of thyroid disorders in populations. Best Pract. Res. Clin. Endocrinol. Metab. 24, 13–27 (2010)
A. Olivieri, C. Di Cosmo, S. De Angelis, R. Da Cas, P. Stacchini, A. Pastorelli, P. Vitti, The way forward in Italy for iodine. Minerva Med. 108, 159–168 (2017)
F. Aghini-lombardi, L. Antonangeli, E. Martino, P. Vitti, D. Maccherini, F. Leoli, T. Rago, L. Grasso, R. Valeriano, A. Balestrieri, The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J. Clin. Endocrinol. Metab. 84, 561–566 (1999)
F. Alghini Lombardi, E. Fiore, M. Tonacchera, L. Antonangeli, T. Rago, M. Frigeri, A.M. Provenazle, L. Montanelli, L. Grasso, A. Pinchera, P. Vitti, The effect of voluntary iodine prophylaxis in a small rural community: the Pescopagano survey 15 years later. J. Clin. Endocrinol. Metab. 98, 1031–1039 (2013)
A. Costa, O. Brambati Testori, G. Cenderelli, Dati sulla endemia di gozzo in Piemonte. G. Accad. Med. 137, 44–61 (1974)
L. Bartalena, E. Masiello, F. Magri, G. Veronesi, E. Bianconi, F. Zerbini, M. Gaiti, E. Spreafico, D. Gallo, P. Premoli, E. Piantanida, M.L. Tanda, M. Ferrario, P. Vitti, L. Chiovato, The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study. J. Endocrinol. Investig. 39, 1445–1451 (2016)
M. Gizak. Global scorecard 2016: moving toward optimal iodine status. Iodine Glob. Netw. 44, 6–9 (2016)
E. Saggiorato, F. Arecco, A. Mussa, C. Sacerdote, R. Rossetto, C. Origlia, L. Germano, D. Deandreis, F. Orlandi, Goiter prevalence and urinary iodine status in urban and rural/mountain areas of Piedmont region. J. Endocrinol. Investig. 29, 67–73 (2006)
F. Cubadda, S. Ciardullo, M. D’Amato, A. Raggi, F. Aureli, M. Carcea, Arsenic contamination of the environment-food chain: a survey on wheat as a test plant to investigate phytoavailable arsenic in italian agricultural soils and as a source of inorganic arsenic in the diet. J. Agric. Food Chem. 58, 10176–10183 (2010)
E. Gaitan, Goitrogens in food and water. Annu. Rev. Nutr. 10, 21–39 (1990)
H. Martínez-Salgado, R. Castañeda-Limones, D. Lechuga-Martín Del Campo, R.I. Ramos-Hernández, M. Orozco-López, J. Rivera-Dommarco, I. Mendoza, C. Magos, Iodine deficiency and other goitrogens in the persistence of endemic goiter in Mexico. Gac. Med. Mex 138, 149–156 (2002)
M. Abraham-Nordling, K. Byström, O. Törring, M. Lantz, G. Berg, J. Calissendorff, H.F. Nyström, S. Jansson, G. Jörneskog, F. Karlsson, E. Nyström, H. Ohrling, T. Örn, B. Hallengren, G. Wallin, Incidence of hyperthyroidism in Sweden. Eur. J. Endocrinol. 165, 899–905 (2011)
J.l. Wémeau, M. Klein, J.L. Sadoul, C. Briet, F.L. Vélayoudom-Céphise, Graves’ disease: introduction, epidemiology, endogenous and environmental pathogenic factors. Ann. Endocrinol. 79, 599–607 (2018)
M.P.J. Vanderpump, The epidemiology of thyroid disease. Br. Med. Bull. 99, 39–51 (2011)
G. Trifirò, R. Gini, F. Barone-Adesi, E. Beghi, A. Cantarutti, A. Capuano, C. Carnovale, A. Clavenna, M. Dellagiovanna, C. Ferrajolo, M. Franchi, Y. Ingrasciotta, U. Kirchmayer, F. Lapi, R. Leone, O. Leoni, E. Lucenteforte, U. Moretti, A. Mugelli, L. Naldi, E. Poluzzi, C. Rafaniello, F. Rea, J. Sultana, M. Tettamanti, G. Traversa, A. Vannacci, L. Mantovani, G. Corrao, The role of European healthcare databases for post-marketing drug effectiveness, safety and value evaluation: where does Italy stand? Drug Saf. 42, 347–363 (2019)
C. Mazzali, P. Duca, Use of administrative data in healthcare research. Intern. Emerg. Med. 10, 517–524 (2015)
M. Bouga, M.E.J. Lean, E. Combet, Contemporary challenges to iodine status and nutrition: the role of foods, dietary recommendations, fortification and supplementation. Proc. Nutr. Soc. 77, 302–313 (2018)
F. Magri, F. Zerbini, M. Gaiti, V. Capelli, L. Croce, S. Bini, A.E. Rigamonti, G. Fiorini, S.G. Cella, L. Chiovato, Poverty and immigration as a barrier to iodine intake and maternal adherence to iodine supplementation. J. Endocrinol. Investig. 42, 435–442 (2019)
Funding
This work was supported by PRIN (Progetti di ricerca di Rilevante Interesse Nazionale) 2015 (2015ZHKFTA_001).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (ethical committee of the “Maggiore della Carità” Hospital, Novara, CE number 60/19) and with the 1964 Helsinki declaration and its later amendments.
Informed consent
The study was conducted using data routinely collected in the regional administrative health care databases in which authors had access to anonymized data only, hence informed consent was not required.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Caputo, M., Pecere, A., Sarro, A. et al. Incidence and prevalence of hyperthyroidism: a population-based study in the Piedmont Region, Italy. Endocrine 69, 107–112 (2020). https://doi.org/10.1007/s12020-020-02222-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-020-02222-7